Simvastatin

Statins protect against subclinical brain damage

Thursday, May 13th, 2010

Source: MedWire News Treatment with simvastatin reduces the occurrence of subclinical cerebral infarcts in patients at risk for large-artery stroke, a post-hoc analysis of the ROCAS study suggests. The ROCAS (Regression of Cerebral Artery Stenosis) study was a randomized, double-blind, placebo-controlled study investigating the effect of daily simvastatin 20 mg on the progression of asymptomatic […]